Repression of arginase-2 expression in dendritic cells by MicroRNA-155 is critical for promoting T cell proliferation

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1690-1700

  Dunand Sauthier, Isabelle ^a   Irla, Magali ^a   Carnesecchi, Stéphanie ^a   Seguín Estévez, Queralt ^a   Vejnar, Charles E ^a   Zdobnov, Evgeny M ^a   Santiago Raber, Marie Laure ^a   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE 2; ARGININE; MESSENGER RNA; MICRORNA 155; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELL LEVEL; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ARGINASE; ARGININE; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 84905971985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301913     Document Type: Article

References (53)

1. Morris, S. M., Jr. 2010. Arginine: master and commander in innate immune responses. Sci. Signal. 3: pe27.
2. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2: 907-916.
3. Wu, G., and S. M. Morris, Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336: 1-17.
4. Jenkinson, C. P.,W.W. Grody, and S. D. Cederbaum. 1996. Comparative properties of arginases. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 114: 107-132.
5. Cederbaum, S. D., H. Yu, W. W. Grody, R. M. Kern, P. Yoo, and R. K. Iyer. 2004. Arginases I and II: do their functions overlap? Mol. Genet. Metab. 81(Suppl. 1): S38-S44.
6. Bronte, V., and P. Zanovello. 2005. Regulation of immune responses by L-Arginine metabolism. Nat. Rev. Immunol. 5: 641-654.
7. Sica, A., and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155-1166.
8. Rodríguez, P. C., and A. C. Ochoa. 2008. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol. Rev. 222: 180-191.
9. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits Tcell receptor expression and antigen-specific T-cell responses. Cancer Res. 64: 5839-5849.
10. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048.
11. Bronte, V., T. Kasic, G. Gri, K. Gallana, G. Borsellino, I. Marigo, L. Battistini, M. Iafrate, T. Prayer-Galetti, F. Pagano, and A. Viola. 2005. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201: 1257-1268.
12. Munder, M. 2009. Arginase: an emerging key player in the mammalian immune system. Br. J. Pharmacol. 158: 638-651.
13. Munder, M., K. Eichmann, and M. Modolell. 1998. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160: 5347-5354.
14. Hesse, M., M. Modolell, A. C. La Flamme, M. Schito, J. M. Fuentes, A. W. Cheever, E. J. Pearce, and T. A. Wynn. 2001. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-Arginine metabolism. J. Immunol. 167: 6533-6544.
15. Munder, M., K. Eichmann, J. M. Morán, F. Centeno, G. Soler, and M. Modolell. 1999. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 163: 3771-3777.
16. Boutard, V., R. Havouis, B. Fouqueray, C. Philippe, J. P. Moulinoux, and L. Baud. 1995. Transforming growth factor-b stimulates arginase activity in macrophages: implications for the regulation of macrophage cytotoxicity. J. Immunol. 155: 2077-2084.
17. Corraliza, I. M., G. Soler, K. Eichmann, and M. Modolell. 1995. Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bonemarrow-derived macrophages. Biochem. Biophys. Res. Commun. 206: 667-673.
18. El Kasmi, K. C., J. E. Qualls, J. T. Pesce, A. M. Smith, R. W. Thompson, M. Henao-Tamayo, R. J. Basaraba, T. König, U. Schleicher, M. S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9: 1399-1406.
19. Mayer, A. K., H. Bartz, F. Fey, L. M. Schmidt, and A. H. Dalpke. 2008. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur. J. Immunol. 38: 1689-1699.
20. Munder, M., F. Mollinedo, J. Calafat, J. Canchado, C. Gil-Lamaignere, J. M. Fuentes, C. Luckner, G. Doschko, G. Soler, K. Eichmann, et al. 2005. Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105: 2549-2556.
21. Bronte, V., P. Serafini, C. De Santo, I. Marigo, V. Tosello, A. Mazzoni, D. M. Segal, C. Staib, M. Lowel, G. Sutter, et al. 2003. IL-4?induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J. Immunol. 170: 270-278.
22. Rodriguez, P. C., A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabaleta, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa. 2003. L-Arginine consumption by macrophages modulates the expression of CD3 z chain in T lymphocytes. J. Immunol. 171: 1232-1239.
23. Deignan, J. L., J. C. Livesay, P. K. Yoo, S. I. Goodman, W. E. O'Brien, R. K. Iyer, S. D. Cederbaum, and W. W. Grody. 2006. Ornithine deficiency in the arginase double knockout mouse. Mol. Genet. Metab. 89: 87-96.
24. Iyer, R. K., P. K. Yoo, R. M. Kern, N. Rozengurt, R. Tsoa, W. E. O'Brien, H. Yu, W. W. Grody, and S. D. Cederbaum. 2002. Mouse model for human arginase deficiency. Mol. Cell. Biol. 22: 4491-4498.
25. Rodriguez, P. C., A. H. Zea, K. S. Culotta, J. Zabaleta, J. B. Ochoa, and A. C. Ochoa. 2002. Regulation of T cell receptor CD3z chain expression by Larginine. J. Biol. Chem. 277: 21123-21129.
26. Louis, C. A., V. Mody, W. L. Henry, Jr., J. S. Reichner, and J. E. Albina. 1999. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am. J. Physiol. 276: R237-R242.
27. Fernández-Ruiz, V., N. López-Moratalla, and A. González. 2005. Production of nitric oxide and self-nitration of proteins during monocyte differentiation to dendritic cells. J. Physiol. Biochem. 61: 517-525.
28. Liscovsky, M. V., R. P. Ranocchia, C. V. Gorlino, D. O. Alignani, G. Morón, B. A. Maletto, and M. C. Pistoresi-Palencia. 2009. Interferon-g priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages. Immunology 128(Suppl. 1)e159-e169.
29. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. Van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
30. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
31. Turner, M., and E. Vigorito. 2008. Regulation of B-And T-cell differentiation by a single microRNA. Biochem. Soc. Trans. 36: 531-533.
32. Ceppi, M., P. M. Pereira, I. Dunand-Sauthier, E. Barras, W. Reith, M. A. Santos, and P. Pierre. 2009. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 106: 2735-2740.
33. Martinez-Nunez, R. T., F. Louafi, P. S. Friedmann, and T. Sanchez-Elsner. 2009. MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J. Biol. Chem. 284: 16334-16342.
34. Zhou, H., X. Huang, H. Cui, X. Luo, Y. Tang, S. Chen, L. Wu, and N. Shen. 2010. miR-155 and its star-form partner miR-155 cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116: 5885-5894.
35. Dunand-Sauthier, I., M. L. Santiago-Raber, L. Capponi, C. E. Vejnar, O. Schaad, M. Irla, Q. Seguín-Estévez, P. Descombes, E. M. Zdobnov, H. Acha-Orbea, and W. Reith. 2011. Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 117: 4490-4500.
36. Mao, C. P., L. He, Y. C. Tsai, S. Peng, T. H. Kang, X. Pang, A. Monie, C. F. Hung, and T. C. Wu. 2011. In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination. Cell Biosci. 1:3.
37. Turner, M. L., F. M. Schnorfeil, and T. Brocker. 2011. MicroRNAs regulate dendritic cell differentiation and function. J. Immunol. 187: 3911-3917.
38. Lu, C., X. Huang, X. Zhang, K. Roensch, Q. Cao, K. I. Nakayama, B. R. Blazar, Y. Zeng, and X. Zhou. 2011. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 117: 4293-4303.
39. Dudda, J. C., B. Salaun, Y. Ji, D. C. Palmer, G. C. Monnot, E. Merck, C. Boudousquie, D. T. Utzschneider, T. M. Escobar, R. Perret, et al. 2013. MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 38: 742-753.
40. Vigorito, E., S. Kohlhaas, D. Lu, and R. Leyland. 2013. miR-155: an ancient regulator of the immune system. Immunol. Rev. 253: 146-157.
41. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based a-And b-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76: 34-40.
42. Steiner, Q. G., L. A. Otten, M. J. Hicks, G. Kaya, F. Grosjean, E. Saeuberli, C. Lavanchy, F. Beermann, K. L. McClain, and H. Acha-Orbea. 2008. In vivo transformation of mouse conventional CD8a+ dendritic cells leads to progressive multisystem histiocytosis. Blood 111: 2073-2082.
43. Vejnar, C. E., and E. M. Zdobnov. 2012. MiRmap: comprehensive prediction of microRNA target repression strength. Nucleic Acids Res. 40: 11673-11683.
44. Shearer, J. D., J. R. Richards, C. D. Mills, and M. D. Caldwell. 1997. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272: E181-E190.
45. Mellor, A. L., and D. H. Munn. 2004. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762-774.
46. Ochoa, A. C., A. H. Zea, C. Hernandez, and P. C. Rodriguez. 2007. Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin. Cancer Res. 13: 721s-726s.
47. Rodriguez, P. C., M. S. Ernstoff, C. Hernandez, M. Atkins, J. Zabaleta, R. Sierra, and A. C. Ochoa. 2009. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69: 1553-1560.
48. Lewis, N. D., M. Asim, D. P. Barry, T. De Sablet, K. Singh, M. B. Piazuelo, A. P. Gobert, R. Chaturvedi, and K. T. Wilson. 2011. Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J. Immunol. 186: 3632-3641.
49. Shi, O., S. M. Morris, Jr., H. Zoghbi, C. W. Porter, and W. E. O'Brien. 2001. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Mol. Cell. Biol. 21: 811-813.
50. Sekine, S., R. Ogawa, M. T. Mcmanus, Y. Kanai, and M. Hebrok. 2009. Dicer is required for proper liver zonation. J. Pathol. 219: 365-372.
51. Norian, L. A., P. C. Rodriguez, L. A. O'Mara, J. Zabaleta, A. C. Ochoa, M. Cella, and P. M. Allen. 2009. Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-Arginine metabolism. Cancer Res. 69: 3086-3094.
52. Selamnia, M., C. Mayeur, V. Robert, and F. Blachier. 1998. a-Difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells. Biochem. Pharmacol. 55: 1241-1245.
53. Baggio, R., F. A. Emig, D. W. Christianson, D. E. Ash, S. Chakder, and S. Rattan. 1999. Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J. Pharmacol. Exp. Ther. 290: 1409-1416.